Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-23-000043 General Corporate
Debt relative to revenue 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
241.44% · OPTIONAL · VALID
Capex intensity 74th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.89% · OPTIONAL · VALID
Operating cash generation 37th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.61% · OPTIONAL · VALID
Share-count growth 82th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.43% · CORE · VALID
Revenue growth 59th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
10.38% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
59.19% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
41.33% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.27% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.18% · OPTIONAL · VALID
SBC intensity 42th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.71% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 143.75%
Current 241.44%
Delta 97.70% Capex Intensity Decreased
Previous 2.31%
Current 1.89%
Delta -0.42% Cash Generation Increased
Previous 9.37%
Current 9.61%
Delta 0.24% Dilution Decreased
Previous -0.41%
Current -0.43%
Delta -0.02% Growth Increased
Previous 6.61%
Current 10.38%
Delta 3.77% Inventory Pressure Increased
Previous 49.49%
Current 59.19%
Delta 9.70% Margin Increased
Previous 40.94%
Current 41.33%
Delta 0.39% Profitability Increased
Previous 16.76%
Current 18.27%
Delta 1.51% R And D Intensity Decreased
Previous 2.25%
Current 2.18%
Delta -0.08% Sbc Intensity Decreased
Previous 0.77%
Current 0.71%
Delta -0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.